Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market
Eli Lilly shares rose 4% on Monday, driven by compelling new data for its next-generation obesity drug, retatrutide, with analysts and investors expecting it to extend the
June 08, 2026
Arizona's 'comma bill' survives last-minute insurance opposition
Woman celebrates 100th birthday with honorary diploma from Saguaro High School
Oklahoma AG Gentner Drummond calls on the Big 12 to sanction Texas Tech for Brendan Sorsby saga
King Charles appoints actor Helen Mirren to a select group in his birthday honors list
Spurs fans still believe they can overcome 3-1 deficit against Knicks to capture 6th NBA title
Japanese investors sought more than $6.2 billion worth of SpaceX shares at IPO, sources say
Trump’s DOJ approves Paramount-Warner Bros. merger, as potential state lawsuits loom
SpaceX’s $2 trillion debut met with cheers, jeers and protest
Wemby, Spurs still believers, even while down 3-1 to Knicks in NBA Finals